Skip to main content

2026 SGLS - Saturday Slides

Page 1


IMF Director, Support Groups

Doctorate -Prepared Nurse| Clinical Nurse Specialist | Support Group Leader

Thank You to our Sponsors!

Thank You to our Donors!

Program Slides & Evaluation

Saturday Morning Agenda

Meeting Patient & Care Partner Needs

Getting Comfortable with Being Uncomfortable

Yara William, DrPh , MHA

AGENDA

Your members are already thinking about these issues!

Silence

can feel like “this isn’t safe to discuss here.”

Getting comfortable with being uncomfortable starts with letting go of the belief that you have to get it right every time.

Setting the “emotional tone” for your group

Creating a safe space for open discussion is the goal

Your role is NOT to fix – it’s to create space

Getting comfortable with being uncomfortable starts with letting go of the belief that you have to get it right every

time.

Why this matters

Common Fears Reframe

What if I say the wrong thing? Curiosity > Expertise

What if I make it worse? Presence > Perfection

What if I don’t have an answer?

Validation > Solutions

Our Core Skills

• Model openness

• Use inclusive language

• Thank people for sharing difficult things

• Avoid shutting down or quickly changing topics

• Normalize that you may feel uncomfortable at times. That’s expected!

You set the emotional permission level of your group.

Our Core Skills

Acknowledge Normalize

Open the Discussion

SEXUAL HEALTH & INTIMACY

Why it’s Tricky

• Quality of life

• Impacts our identity

• Partner disagreement

• Rarely discussed openly

• Cultural discomfort

• Dating while living with myeloma

Understanding the Challenges

Desire or Libido

Desire can change because of treatment, fatigue, stress, or hormones.

Orgasm & Arousal

Treatment or medications can change orgasm or sexual response.

Pain

Pain or fear of pain can make intimacy difficult.

Body Image

Physical changes can affect confidence and closeness.

Hormones

Hormonal changes can affect desire, mood, energy, and function.

Stress

Stress can affect intimacy, communication, and desire.

Acknowledge, Normalize, Open the Discussion

"Thank you for sharing that.

That can be a really difficult change to experience.

Treatment can affect intimacy – there is no doubt about that. It’s a common concern that we can talk about here, safely.

Has anyone else experienced something similar and found ways to navigate it?"

Tips & Resources

Redefining Intimacy

Adapting to new normal

Local oncology social workers

Sexual health therapists

Pelvic floor physical therapy

Remember that sexual dysfunction is only dysfunction if the person experiencing it feels that it is.

There is no one definition of a healthy sex life.

MISINFORMATION & “MIRACLE CURES”

Why it’s Tricky

• Common Forms: Unproven, off -label products, remissions credited to lifestyle alone

• Correcting too quickly can damage trust

• Members often share out of hope or fear, not bad intent

• The line between complementary and harmful is not always clear

• Social media and podcasts spread claims rapidly

• Some members feel dismissed by their care teams

Acknowledge, Normalize, Open the Discussion

Tips & Resources

• Respond to the emotion first: hope, fear, frustration, or distrust

• Care team: your first source for treatment questions

• IMF Resources: IMF InfoLine , educational material, Myelo

• National Cancer Institute: cancer.gov, 1 -800 -4 -CANCER

• Memorial Sloan Kettering Cancer Center: MSK About Herbs for supplement safety (mskcc.org)

FINANCIAL TOXICITY

Understanding the Challenges

Copays & Medication

C osts

High out -of -pocket costs for treatment, supportive medicines, and specialty drugs.

Lost Income

Patients and care partners may miss work, reduce hours, or leave employment.

Insurance S tress

Prior authorizations, denials, Medicare choices, and plan changes can be confusing.

Travel & L odging

Appointments, transplant, CAR T, or clinical trials may require travel and overnight stays.

Care P artner C osts

Childcare, gas, parking, meals, and time away from work add up.

Treatment

D ecisions

Some members may delay care, skip medication, or avoid appointments because of cost.

Acknowledge, Normalize, Open the Discussion

Tips & Resources

Where to start:

• Create permission: “Cost is part of the cancer experience, and it is okay to talk about it.”

• Encourage early help: oncology social worker, financial counselor or navigator

• Connect to resources: IMF InfoLine , Myelo , HealthWell , Triage Cancer, Medicare Extra Help, SSDI, American Cancer Society, Blood Cancer United

CONFLICT WITHIN THE GROUP

Understanding the Challenges

Advice vs. Support

Members may tell others what they “should” do instead of sharing their own experience.

Misinformation

Unproven claims can create tension when others disagree or feel unsafe.

Dominating Voices

One person may take over, interrupt, or respond to every comment.

Treatment

Comparison

Members may compare doctors, outcomes, risk, or prognosis in ways that create fear.

Patient/Care Partner

Tension

Patients and care partners may experience the same situation differently.

Leader Discomfort

Leaders may delay intervening because they want to be kind or avoid conflict.

Acknowledge, Normalize, Open the Discussion

Tips & Resources

• Set group agreements early: respect, confidentiality, no medical advice, share from “I” statements

• Intervene early and calmly; silence can look like agreement

• Use neutral language and redirect advice into experience.

• Take repeated or personal conflict offline when needed

• Ask IMF staff for support when conflict affects safety, trust, or group participation. Co -lead to avoid burnout.

GRIEF WITHIN THE GROUP

Understanding the Challenges

Anticipatory Grief

Patients and care partners may grieve future losses before they happen.

Cumulative Loss

Repeated losses can build overtime for long -standing groups.

Member Deaths

A death may affect the whole group, especially close members or leaders.

Survivor’s Guilt

Members may wonder why they are doing well when others are not.

Ambiguous Loss

People may grieve changes in identity, energy, independence, roles, or plans.

Different Grieving

Styles

Some need to talk, some need silence, some need privacy, and all can be valid.

Acknowledge, Normalize, Open the Discussion

Tips & Resources

Grief and bereavement support

• Allow silence, tears, memories, mixed emotions

• Allow creative space for remembrance and honor

• Know when to connect members to extra support

o CancerCare bereavement support

o Local hospice bereavement programs, often free

o Oncology social workers and grief counselors

o Clergy/faith leader

o 988 Suicide and Crisis Lifeline (call or text 988)

END OF LIFE DISCUSSIONS

Understanding the Challenges

Anxiety

Waiting for results of lab work on scans can be a huge source of stress.

Toxic Positivity

Only focusing on positive emotions while dismissing or minimizing difficult ones

Differing Experiences

Patients & their care partners share the same situation, but through different lenses.

Cultural & Familial Differences

Beliefs about death, advance care planning, hospice, & family decisionmaking can vary.

Simultaneous

Emotions

Rarely does one feel only one emotion at a time. They are not mutually exclusive.

Myth of

Removing Hope

Talking about the endof -life doesn’t have to remove hope.

Balancing Hope

Continuing to cultivate hope, even during challenging times.

Gaining Control

Education can make people feel more prepared, informed, and in control.

Understanding the Challenges

Acknowledge, Normalize, Open the Discussion

Tips & Resources

Things to Do:

• Encourage palliative care from diagnosis

• Provide dignity & respect

• Create space for values & goals

Things to Avoid:

• Judgment

• False reassurance

• Shutting down emotion

• Using the term “Stopping Care”

Conclusion

These are all very different conversations, but the way that we show up for them as support group leaders remains the same:

Curiosity, Presence, Validation

Stretch & Morning Break

Advocacy in Action: Conversations with Patient Advocates

Advocacy in Action: Conversations with Patient Advocates

Eric Blackburn (Veterans Only)
Jessie Daw, PhD (Sioux Falls, SD | Smolder Bolder)
Chad Moore (Bloomington, IL)
Carol Smith (Denver, CO)

Advocacy in Action: Conversations with Advocates

Creating Community Through Social Media

Adrienne Moore

Bloomington, IL | MM in the Middle

Regeneron

The Art of Support Group Leadership: Fireside Q&A

Morning Session

Lunchtime 12:00 - 12:55 PM

Program Slides & Evaluation

Saturday Afternoon Agenda

Sharing CoMMunity Collaborations

Katie Atkins MSW, LCSW,

LCAS, CCS, OSW -C

Ashville, NC | Solo and Strong

Sharing CoMMunity Collaborations

Oya Gilbert (Hagerstown, MD)
Todd & Diane Kennedy (Duarte, CA)
Paul & Jeanne Knudsen (Palm Beach County, FL)

TRUST

Culture is our bridge.

COLLABORATION

Meet people where they are.

IMPACT

Together we reach farther.
“When healthcare speaks the language of the community... communities respond."

THANK YOU

Todd & Diane Kennedy

City of Hope Support Group Leaders

Todd Diagnosed 2017

The Harsh Reality of: “You Have Multiple Myeloma”

How long will I live?

Where do I go for care?

Where do we go for information?

▪ Dr. Google – scary, outdated stats

▪ Facebook – sometimes helpful, often depressing

▪ Friends, family, coworkers

Overwhelmed

Move MORE people from fear to hope… QUICKLY! Call to Action

Provide critical support, education, and resources to patients EARLY in their myeloma journey

Community Market Analysis

~23.3 million people live in 10 Southern California counties

~12,600 people are living with myeloma in SoCal

~1,700 people will be diagnosed with myeloma in SoCal each year (Almost 5 per day!)

Source: SEER 2026

City of Hope has the largest myeloma program in Southern California

Most myeloma specialists

Most stem cell transplants and CAR -Ts

Most research / trials

Greatest number of myeloma patients

Our Proposal

▪ Offered to facilitate a monthly “Navigating Multiple Myeloma Workshop” for City of Hope

▪ Presented the concept to the myeloma leadership team, the social worker team, and supportive care services leadership

▪ Agreed to co -create content, and co -own and co -promote the workshops

Refining the Strategy

▪ Fully virtual – goal to offer to patients at all City of Hope facilities (SoCal, Chicago, Atlanta, and Phoenix)

▪ Back -to -back monthly sessions –1st hour Navigation Workshop and 2nd hour

Co MM unity Connection Support Group – meet the 3 rd Wednesday of the month

▪ Partnership and co -promoted with the IMF

Navigation Workshop Agenda

3-4 pm PT / 5-6 pm CT / 6-7 pm ET

■ Introduction - Our Myeloma Journey

■ Myeloma Basics and Treatments

■ Reasons for HOPE

■ Preparing for Your Doctor Visits

■ Resources for Education and Support

■ Tips for Patients and Care Partners

■ Questions and Answers

Co MM unity Connection Agenda

4 -5 pm PT / 6-7 pm CT / 7-8 pm ET

■ Introductions

■ Upcoming Events and Support Group Meetings

■ Monthly Dose of Hope

■ Trial Spotlight

■ Guest Speaker: Dr. Lisa Lee Myeloma Specialist from City of HopeIrvine

■ Patient & Care Partner Sharing Forum (Voluntary )

Save the Date

International Myeloma Foundation Patient and Family Seminar

Los Angeles

▪ August 14 -15 at The Hilton Los Angeles/Universal City

▪ For more details and to register:

Los Angeles, CA, Patient and Family Seminar 2026 |

International Myeloma Foundation

International Myeloma Foundation Community Workshop

San Diego

▪ October 24 at The Westin San Diego Bayview

▪ For more details and to register:

San Diego, CA, Myeloma Community Workshop 2026 |

International Myeloma Foundation

City of Hope Walk for Hope

▪ November 8 in Irvine

▪ To join our CoH Myeloma Co MM unity Team

click here: https://ourhope.cityofhope.org/team/825214

SoCal IMF Support Groups

Inland Empire Myeloma Support Group

Thursday, June 4 at 3 pm (Hybrid)

Stephen Daub, DPT

Email Jackie Sarlitt at ocmmsg@imfsupport.org for details

TONIGHT, May 20 at 7 pm

Orthodontist Dr. Neil Kaplan

Osteonecrosis of the Jaw and Related Dental Topics

Zoom Meeting Link: https://us02web.zoom.us/j/88120752860

https://www.myeloma.org /support -groups

Meets hybrid the 3 rd Saturday of the month at 11 :00 AM

Los Angeles Myeloma Support Group

Meets virtually on the 3 rd Saturday of the month at 10:30 AM

Orange County Myeloma Support Group

Meets virtually or hybrid on the 1 st Thursday of the month time varies

Rancho Mirage Myeloma Support Group

Meets in -person on the 1 st Thursday of the month at 3 PM

San Diego Myeloma Support Group

Meets hybrid the 2 nd Monday of the month at 6:30 PM

San Fernando Valley Myeloma Support Group

Meets virtually or in -person the 3 rd Wednesday of the month at 7 PM

San Gabriel Valley Myeloma Support Group

Meets in -person the 1 st Monday of the month at 6:30 PM

Upland Myeloma Support Group

Meets hybrid the 1 st Friday of the month at 10 AM

Westlake Myeloma Support Group

Meets virtually the 2 nd Saturday of the month at 11 AM

Membership Statistics

▪ 149 members as of June 2026 (less than 2 years)

▪ 71 (48%) “newly diagnosed members” (NDMM)

▪ Approximately 2-5 NEW members attend the Navigation Workshop – with additional repeat attendees

▪ The MAJORITY of attendees were NOT connected to an existing support group prior to attending ours – but we now see them on our other SoCal IMF support group Zoom calls

▪ Greater than 74% repeat attendance (3 meetings or more)

▪ Well -reviewed through monthly surveys, rated as “strongly agree” for providing education, empowerment, and feeling connected

Multi -Channel Promotion

▪ Doctors and care team referrals

▪ Members sharing about the group with other patients and their doctors/care team

▪ Referrals from other support group leaders

▪ City of Hope -branded marketing:

▪ Flyers around the facilities and available for doctors/care team to share

▪ Ads on TV screens in cancer center lobby, waiting areas, and exam rooms

▪ Articles in the City of Hope newsletter

▪ IMF -branded flyers, IMF website, and on other non -profit websites

Fear to Hope

“Loved hearing positive stories being newly diagnosed in March.”

“Please continue to offer this exact zoom support session --it helps so many of us dealing with this blood cancer. It's a perfect complement to the professional care the doctors at City of Hope offer.”

“As

my husband's care partner, I felt overwhelmed. I don't feel alone anymore.

I got a lot out of this workshop. I will definitely attend next month.”

“This group is something to look forward to, it keeps me hopeful.”

Reach the Unreached

▪ Collaborate, co -create, and co -own

▪ Co -promote through multiple channels

▪ It is NOT “This OR That” – it is “This AND that”

Increase touchpoints – connect virtually through multiple groups and encourage in -person connections

Measure, refine, and grow

Celebrate Connections!

The Science & Art of Outreach

~192,000 people living with myeloma in the US

~36,000 newly diagnosed each year

That is ~100 new patients each day!

Through

collaboration

and

connection,

we move MORE people from fear to hope

Medical Student

Connections with Myeloma Patients

Humble Beginnings

• Steve Weinstein made strides to establish a relationship with the medical school at Nova.

• Steve arranged for myeloma patients, Paul & Jeanne, to share their experience as patients and care partners directly to first year medical students.

Making the Vision a Reality

• Paul was initially invited to speak to first year medical students in 2019.

• Most recently, Paul and Jeanne spoke to students in 2025.

• Here is a link to that presentation: Paul & Jeanne speak to Nova Students

Presentation to Nova Southeast University

Paul & Jeanne reminded medical students:

• “We’re real people!”

• “No two patients are the same.”

• Don’t neglect to address the emotional impact of a diagnosis of multiple myeloma.

• Ask care partners and family members how they are doing.

Presentation to Nova Southeast University

Paul & Jeanne also:

• Reinforced shared decision making and patient autonomy

• Encouraged honest conversations with patients, eye contact, and to slow down

• Asked new doctors to refer to Multiple Myeloma support groups

Following the Presentation

• Many students and doctors came forward to express thanks and appreciation

• Jenna asked if she could be involved with their Multiple Myeloma Support Group.

Connecting Students with the IMF

Paul worked with IMF staff to arrange for students to be invited to the Patient and Family Seminar in Boca Raton in March, 2026.

Boca Raton Patient & Family Seminar

• Dr. Joe publicly recognized this group of students during his talk on Friday.

• Students were able to interact directly with patients, care partners, and myeloma specialists.

The Touching Reality

• One of the students disclosed that his father was diagnosed with Multiple Myeloma just 2 weeks prior.

• The hematologist working with this student’s father was a presenter at the seminar; the student was able to speak directly with him.

Warm Thanks

This connection has allowed patients to directly inform future doctors about myeloma and promote awareness and empathy for the patient & care partner experience.

Beyond Boundaries: Transforming Myeloma Care with

Innovation

AGENDA

THE MYELOMA KNOWLEDGE PLATFORM

The Myeloma Knowledge Platform (MKP): Core Tools

myeloma.org

The trusted home of the MKP — one place for every tool plus education, webinars, and support.

#HelloMyelo

24/7 GenAI assistant offering myeloma education, treatment guidance, and trial and financialsupport information.

Trial Matching (CTME)

Powered by SparkCures — matches patients to relevant trials and guides them from exploration to enrollment.

Myelo MD

MyeProfile

Single sign -on across all myeloma.org tools, with content personalized by location and diagnosis stage.

AI clinical decision support giving non -specialist physicians traceable, specialist -level guidance at the point of care.

IN DEVELOPMENT

#HELLOMYELO

Myeloma Support Chatbot: #HelloMyelo

GenAI Chatbot Myelo :

The first generative AI assistant designed specifically for multiple myeloma.

Launched Sept 15, 2024

Myelo Platform Performance

Myelo Frequently Asked Questions

• What is multiple myeloma?

• What causes multiple myeloma?

• What are the symptoms and signs of MM?

• How is multiple myeloma diagnosed?

• What are the different types of myeloma?

• What are the possible side effects of multiple myeloma treatments?

• What is the standard of care options for frontline treatment?

WHERE MYELO IS HEADED

Where Myelo Is Headed: Phase III + Myelo MD

MYELO PHASE III | Myeloma Manager

Personalized care coordination

A personal organization hub for patients to track appointments, medications, and side effects — designed as a non-medical-device tool.

AI-powered information

Contextual myeloma knowledge delivered based on treatment phase, stage, and patient-stated priorities, available 24/7.

Care team preparation

Appointment prep tools, question generators, and lab result summaries to help patients arrive ready for every visit.

MD | Clinician Tools

Clinical decision support

AI-assisted differential reasoning to support diagnosis and staging decisions in complex myeloma presentations.

Patient-facing summary tools

Generate plain-language summaries of treatment plans and lab results that patients can review independently.

Real-world data integration

Aggregate de-identified patient data to surface populationlevel insights for clinical and research contexts.

Caregiver co-design

Built for family members and care partners to use alongside patients, with accessibility for older adults.

Clinician efficiency

Reduce time spent on patient education and FAQ responses by routing common questions to Myelo tools.

MYELO

HOW CLINICIANS ARE USING AI

How Clinicians Are Using AI

Diagnostic support

AI analyzes bone marrow biopsies and flow cytometry data to identify abnormal plasma cells earlier and more consistently.

Risk stratification

ML models combine cytogenetics, labs, and ISS/R -ISS staging to predict relapse risk and guide frontline regimen selection.

Treatment decisions

Clinical decision support tools recommend regimens for relapsed/refractory disease based on prior lines and approved guidelines.

MRD monitoring

Deep learning applied to NGS and mass spectrometry detects minimal residual disease below conventional testing thresholds.

Clinical trial matching

Clinical Trial Matching Engine maps patient profiles to open eligibility criteria in real time.

Imaging analysis

AI reads whole -body PET/CT and MRI to detect lytic lesions, track bone disease, and quantify tumor burden simultaneously.

WHAT PATIENTS THINK ABOUT AI

Patient Perspectives on AI in Healthcare

What Patients Want from AI

Lab-result tracking + plain language

Medication & appointment reminders

Question generation for visits

Side-effect & symptom triage

Insurance & billing assistance

Care-record consolidation

Nutrition & lifestyle guidance

Clinical trial matching

TALKING TO AI TOOLS

Writing a Better Prompt: The SPACE Framework

Give every AI prompt these five elements — works with Myelo, ChatGPT, Claude, and Gemini.

Situation

Who you are and your current disease status. Include stage, lines of therapy completed, and whether you are newly diagnosed, in remission, or relapsed.

Purpose

What you are trying to accomplish. Understand a test result? Prepare questions for your oncologist? Learn about side effects?

A

C

Ask

The specific question you want answered. Be direct. One focused question per prompt gets better results than several bundled together.

Context

Relevant details: specific drug names, lab values such as M-protein or free light chains, your doctor’s recent comments, or treatment start dates.

Expectations

Tell the AI how you want the answer: plain language, a short summary, a numbered list, or a comparison table.

Putting SPACE Into Practice

WEAK PROMPT

“Tell me about my myeloma treatment options.”

More example prompts you can use today:

STRONG PROMPT USING SPACE

“I have IgG kappa myeloma, diagnosed 2022, completed VRd frontline. I am considering a clinical trial. List 3 key questions to ask my oncologist about CAR -T eligibility. Use plain language.”

Understanding a lab result My free light chain ratio is 4.2. I am in remission after 4 cycles of daratumumab, lenalidomide, and dexamethasone. What does this ratio mean and what should I watch for? Keep it to 3 sentences.

Preparing for an appointment I have a follow -up about starting maintenance lenalidomide. I am 68 years old and concerned about fatigue and neuropathy. Give me 5 specific questions to ask my doctor.

Understanding a new treatment I heard about teclistamab for relapsed myeloma. I have had 3 prior lines. Compare teclistamab to CAR -T in a short table: how they work, how they are given, and main side effects.

Staying Safe: What AI Can and Cannot Do

AI tools like Myelo CAN:

Explain myeloma terms and test results in plain language

Summarize treatment options based on current IMWG guidelines

Help you prepare specific questions for your care team

Provide background on clinical trials relevant to your disease

Walk through side effect profiles for specific drugs

Provide information 24 hours a day, between clinic visits

AI tools CANNOT replace:

x Your oncologist’s clinical judgment about your individual case

A formal medical diagnosis or treatment prescription

x Access to your real -time lab values or imaging results

Emergency medical care — always call 911 or your care team

Guaranteed accuracy — always verify important answers with your doctor

x Persistent session memory — re -provide your context each session

Tip: Keep a short disease summary on your phone — diagnosis date, stage, current treatment, line of therapy. Paste it at the start of any AI conversation to get better, more personalized answers.

STAYING SAFE ONLINE

Protecting Your Privacy When Using AI Health Tools

YOUR DATA AND PRIVACY RIGHTS

What AI tools see

Reputable AI health tools do not store or sell your personal health information. Myelo does not collect your name, contact details, or insurance information. You control what you share.

What to never enter

Do not type your Social Security number, Medicare or insurance ID, date of birth combined with your full name, or financial account numbers into any AI chat tool.

PHISHING: HOW TO SPOT A FAKE

Fake IMF emails and texts

The IMF will never ask you to click a link to "verify your Myelo account" or "claim your free AI health report." These are phishing attempts. Forward suspicious emails to webteam @myeloma.org.

Urgency and fear tactics

Messages that say "Your account will be deleted" or "Act now to protect your health data" are designed to panic you into clicking. Legitimate health organizations do not send threats.

Check the privacy policy

Before using any health AI tool, look for a clear privacy policy. If you cannot find one, do not use the tool. The IMF's privacy policy is at myeloma.org/privacy.

Public Wi -Fi risk

Avoid using AI health tools on public Wi -Fi networks in airports, hotels, or coffee shops. Use your home network or mobile data when discussing personal health details.

Suspicious links

Hover over any link before clicking. Legitimate IMF links always go to myeloma.org. Watch for misspellings like myel0ma.org or imf -myeloma.net.

Caller ID spoofing

Scammers can make calls appear to come from real hospitals or the IMF. If an unexpected caller asks for your Medicare ID or asks you to download an app, hang up and call the organization back directly.

AI -Related Scams Targeting Patients: What to Watch For

Scammers use AI to sound more convincing. These tactics are real and increasing.

! "AI -powered cure" offers

No AI tool can diagnose, cure, or predict your myeloma outcome. Ads or websites promising AIgenerated cure protocols or personalized treatment plans for a fee are scams.

! Fake clinical trial recruitment

Legitimate trials do not charge enrollment fees or ask for insurance information upfront via text or social media. Verify every trial at clinicaltrials.gov or through your oncologist.

! Impersonation of Myelo or the IMF

Fraudsters clone the look of Myelo or myeloma.org. Check the full URL before entering anything. The real platform is at myeloma.org. Report imposters to support@myeloma.org.

! "Free AI health scan" requests

Offers of a free AI scan of your test results in exchange for uploading lab documents are data harvesting. Your labs contain sensitive identifiers. Never upload them to an unknown site.

! AI chatbots asking for payment

Myelo is free. Any AI tool that claims to be affiliated with the IMF and asks for a subscription, donation, or co -pay to continue is fraudulent.

! Social media health AI accounts

Unofficial Facebook, Instagram, or TikTok accounts posing as IMF AI tools may collect your information or spread misinformation. The IMF's official accounts are listed at myeloma.org.

Never pay: legitimate AI health tools from trusted organizations are free. Never upload: lab results or insurance cards to an unfamiliar site. When in doubt: call the IMF Infoline at 1 -800 -452 -CURE (2873).

The Art of Support Group Leadership: Afternoon Fireside Q&A

Day 2 Wrap -Up

Jenn Wieworka, DNP, RN, OCN

Leader Learning Labs & Networking Opportunities

• Social Media with Adrienne Moore (Hammond)

• Wellness through Origami with Jill Schock (North Shore)

• Tech Help with Miko & Cecilia (Aurora)

• Reimbursements & SG Funds Assistance with Jenn & Yara (Prefunction Area)

• Networking by the Pool

• Walk around Viking Lake

• Lawn Games (Valhalla Terrace)

• Rest & Relax

5:30PM – Networking & Evening Reception (Valhalla Terrace & Prefunction North)

6:00PM – Dinner (Valhalla Ballroom)

Tomorrow: 7:30 – 8:30AM – Breakfast (Prefunction North)

Program Slides & Evaluation

Thank You to our Sponsors!

Thank You to our Donors!

Turn static files into dynamic content formats.

Create a flipbook
2026 SGLS - Saturday Slides by International Myeloma Foundation - Issuu